Rituximab is a chimeric mouse/human monoclonal antibody (mAb) therapy with binding
specificity to CD20. It was the first therapeutic antibody approved for oncology patients and …

Lymphoma is a malignant lymphoproliferative tumor that can involve the conjunctiva.
Approximately 5–15% of all extranodal lymphomas are found in the ocular adnexal region …

Ocular cancers represent a rare pathology. The American Cancer Society estimates that
3,360 cases of ocular cancer occur annually in the United States. The major types of cancers …

Purpose To examine the molecular biological differences between conjunctival mucosa-
associated lymphoid tissue (MALT) lymphoma and orbital MALT lymphoma in ocular adnexa …

Objective To report the efficacy and toxicity of External beam Radiotherapy (EBRT) as a sole
treatment for MALT and Follicular Primary Orbital and Ocular adnexal Lymphoma (POOAL) …

Lymphoma is the most common primary tumor of the orbit, accounting for 55% of all orbital
malignancies. When divided into histopathological subtypes, extranodal marginal zone …

Background Laboratory experiments were conducted to evaluate the bio-efficacy and
cumulative effect of entomopathogenic fungi (EPF), viz., Lecanicillium lecanii (Zimmermann) …

There have been rapid advancements in the field of ocular oncology for the diagnosis and
management of intraocular, adnexal, and orbital tumors. Targeted therapy is in the forefront …

Background This study evaluates the oncological outcomes and toxicities of indolent ocular
adnexal and orbital lymphomas (OOLs) treated with radiotherapy (RT)±systemic therapy …

Introduction Involved site radiation therapy (ISRT) is a widely used treatment for primary
ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma with control rates …